Theratechnologies Inc. (TSE:TH - Get Free Report)'s stock price passed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of C$1.71 and traded as high as C$1.81. Theratechnologies shares last traded at C$1.78, with a volume of 123,064 shares.
Theratechnologies Trading Down 0.6 %
The stock has a fifty day moving average of C$1.71 and a two-hundred day moving average of C$1.80. The company has a market capitalization of C$81.38 million, a PE ratio of -9.89, a PEG ratio of -8.50 and a beta of 1.73. The company has a current ratio of 1.10, a quick ratio of 0.64 and a debt-to-equity ratio of 562.07.
Theratechnologies (TSE:TH - Get Free Report) last issued its quarterly earnings data on Thursday, October 10th. The company reported C$0.09 earnings per share (EPS) for the quarter. The business had revenue of C$30.96 million for the quarter. Theratechnologies had a negative net margin of 8.47% and a negative return on equity of 1,116.86%. As a group, sell-side analysts anticipate that Theratechnologies Inc. will post 0.0298643 earnings per share for the current fiscal year.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc, a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA SV for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo for the treatment of HIV-1 infection in heavily treatment-experienced adults with multidrug-resistant HIV-1 infection failing their current antiretroviral regimen.
Read More
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.